国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2014年
14期
2107-2109
,共3页
亚临床外周动脉疾病%血液透析%腹膜透析%生存分析
亞臨床外週動脈疾病%血液透析%腹膜透析%生存分析
아림상외주동맥질병%혈액투석%복막투석%생존분석
Peripheral artery disease%Hemodialysis%Peritoneal dialysis%Survival analysis
目的 探讨合并有亚临床外周动脉疾病的终末期肾病患者采用血液透析及腹膜透析的生存率.方法 纳入2010年1至6月在我院规律行肾脏替代治疗的患者进行筛选亚临床外周动脉疾病.记录其相关临床资料,随访至201 3年6月,评估患者预后情况.结果 经筛选,83例患者合并有亚临床外周动脉疾病(血液透析53例,腹膜透析30例),Kaplan-Meier生存分析提示血液透析患者较腹膜透析患者生存率更好(P=0.045).结论 在合并有亚临床外周动脉疾病的患者中,或许更适合选择血液透析作为肾脏替代治疗方式.
目的 探討閤併有亞臨床外週動脈疾病的終末期腎病患者採用血液透析及腹膜透析的生存率.方法 納入2010年1至6月在我院規律行腎髒替代治療的患者進行篩選亞臨床外週動脈疾病.記錄其相關臨床資料,隨訪至201 3年6月,評估患者預後情況.結果 經篩選,83例患者閤併有亞臨床外週動脈疾病(血液透析53例,腹膜透析30例),Kaplan-Meier生存分析提示血液透析患者較腹膜透析患者生存率更好(P=0.045).結論 在閤併有亞臨床外週動脈疾病的患者中,或許更適閤選擇血液透析作為腎髒替代治療方式.
목적 탐토합병유아림상외주동맥질병적종말기신병환자채용혈액투석급복막투석적생존솔.방법 납입2010년1지6월재아원규률행신장체대치료적환자진행사선아림상외주동맥질병.기록기상관림상자료,수방지201 3년6월,평고환자예후정황.결과 경사선,83례환자합병유아림상외주동맥질병(혈액투석53례,복막투석30례),Kaplan-Meier생존분석제시혈액투석환자교복막투석환자생존솔경호(P=0.045).결론 재합병유아림상외주동맥질병적환자중,혹허경괄합선택혈액투석작위신장체대치료방식.
Objectives To explore the survival rate of the patients with subclinical peripheral artery disease (PAD) undergoing peritoneal dialysis (PD) and hemodialysis (HD).Methods Patients regularly undergoing renal replacement therapy at our hospital from January to June,2010 were recruited into this study to screen subclinical peripheral artery disease.The clinic data were recorded.The patients were followed up to June,2013.The prognosis were assessed.Results After the screening,83 patients,53 undergoing hemodialysis and 30 peritoneal dialysis,had subclinical peripheral arterial disease.Kaplan-Meier survival analysis showed that the survival rate was higher in patients taking HD than in those taking PD (P=0.045).Conclusions For patients with subclinical peripheral artery disease,HD may be a better choice as renal replacement therapy comparing with PD.
